NEW YORK (GenomeWeb News) – The German biomedical software company Life Biosystems has licensed entity recognition software from the Fraunhofer Institute for Algorithms and Scientific Computing, and the parties will work together to develop clinical research algorithms.
The ProMiner software covered under the agreement is used for named entity recognition in, biology, medicine, and chemistry, Life Biosystems said.
The collaboration will aim to identify and develop models of therapeutically relevant clinical and lexical information, and will emphasize a drug’s mode of action and the clinical outcome.
Life Biosystems Director of In Silico Discovery David Jackson said that the collaboration will help the company “efficiently bridge the gap between the clinical and molecular information domains,” which could allow innovations in analysis and application of derived data.
"The collaboration with Life Biosystems fits perfectly with our overall strategy to further develop our text-mining technologies for application areas beyond biology” said Julian Fluck, who is head of the text mining group at Fraunhofer SCAI.
Financial terms of the agreement were not released.